Alkermes PLC (ALKS): Rega marang dodolan

Logo korporat perusahaan Alkermes PLC (ALKS)

Alkermes plc (ALKS) is implementing "green chemistry" to minimize toxic laboratory emissions. The revenue multiple reflects the market valuation of sales, with 4.50 becoming the new value for this metric. The monopoly potential of neurobiology patents ensures high margins, while a stable staff of leading scientists guarantees the preservation of intellectual capital and the protection of R&D competencies.

Rasio rega marang pendapatan: alkermes.com (ALKS) kanggo 04.07.2022 - 13.11.2026

Rincian analitis perusahaan Alkermes Inc. (ALKS)

- rega saham lan konsensus proyeksi valuasi:
Bagan owah-owahan rega alkermes.com|ALKS - Bagan rega target
- data kapitalisasi bursa:
Nilai pasar Alkermes Inc.|ALKS - Nilai Perusahaan
- data nilai buku modal saham:
Nilai Buku saben Saham Alkermes|ALKS - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku alkermes.com|ALKS - Aset Agregat Perusahaan
- statistik kawajiban utang lan likuiditas:
Total Utang marang Modal Alkermes plc|ALKS - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Alkermes Corp|ALKS - Utang perusahaan|Rasio utang marang aset resik Alkermes Inc.|ALKS - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Alkermes|Likuiditas darurat alkermes.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
ALKS - Bathi resik perusahaan|Prakiraan bathi perusahaan Alkermes plc|ALKS - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi Alkermes PLC|ALKS - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan Alkermes Inc.|ALKS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Alkermes|ALKS - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan alkermes.com|ALKS - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Alkermes plc
- data total pendapatan lan volume dodolan:
ALKS - Pendapatan perusahaan|Prakiraan pendapatan perusahaan alkermes.com|ALKS - Rasio rega marang pendapatan|Multiplikator Forward P/S Alkermes Inc.
Analisis fundamental perusahaan:alkermes.com, ALKS
Produk mawa merek Alkermes

Steady demand for Alkermes plc (ALKS) psychiatric medications makes the P/S divergence from its historical average a precise indicator of market distortions relative to actual sales. This metric correlates market capitalization with annual revenue, allowing investors to determine whether the asset's current price is justified by the volume of generated cash flows or if the market is unjustifiably overvaluing the business.

Pesaing Alkermes plc

AVDL (avadel.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan atai Life Sciences ATAI|GH Research plc (GHRS) - Rega marang dodolan|MindMed Inc. - Multiplikator P/S|CMPS - Multiplikator P/S|LB Pharmaceuticals Inc (LBRX) - Rasio rega marang pendapatan|DRUG (brightmindsbio.com) - Rasio rega marang pendapatan|Rasio rega marang pendapatan Vanda Pharmaceuticals Inc.|Multiplikator P/S Cybin Corp|Multiplikator P/S ANRO|NRXP - Rega marang dodolan|Rasio rega marang pendapatan Cingulate CING|Rasio kapitalisasi pasar marang pendapatan SILO|CPHI - Rasio rega marang pendapatan|clearmindmedicine.com (CMND) - Kapitalisasi marang pendapatan|PBM: Multiplikator P/S|Rega marang dodolan SciSparc Corp (SPRC)|Rasio rega marang pendapatan Seelos Therapeutics|Virpax (VRPX) - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan KRTX (Karuna Therapeutics, Inc.)